Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-054678
Filing Date
2020-11-19
Accepted
2020-11-19 17:16:16
Documents
71
Period of Report
2020-11-19

Document Format Files

Seq Description Document Type Size
1 6-K mito-6k_20201119.htm 6-K 1471568
  Complete submission text file 0001564590-20-054678.txt   5526938

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mito-20201118.xml EX-101.INS 958630
3 XBRL TAXONOMY EXTENSION SCHEMA mito-20201118.xsd EX-101.SCH 60699
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mito-20201118_cal.xml EX-101.CAL 39306
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mito-20201118_def.xml EX-101.DEF 167573
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mito-20201118_lab.xml EX-101.LAB 406413
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mito-20201118_pre.xml EX-101.PRE 327677
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 201329602
SIC: 2834 Pharmaceutical Preparations